Tuesday, May 15 at 9pm EDT #AskASN returns for a discussion of belatacept with transplant experts Matthew Ellis, MD from Duke and Silvi Shah from Cincinnati.
Here is a visual abstract by Aakash Shingada on the BENEFIT trials to wet your appetite.
Background
This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.
Background
This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
